GILD vs RVMD
Gilead Sciences, Inc. - Common Stock · Revolution Medicines, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | GILD | RVMD |
|---|---|---|
| Price | $132.73 | $180.92 |
| Market Cap | $164.79B | $38.46B |
| P/E | 19.36 | — |
| P/B | 7.01 | 25.64 |
| P/S | 5.60 | — |
| ROE | 36.2% | -75.4% |
| Net Margin | 28.9% | — |
| Gross Margin | — | — |
| Revenue Growth | 2.4% | — |
| Dividend Yield | 2.38% | — |
| EPS | $6.85 | -$5.32 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.